Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

4 results about "Arthritis" patented technology

A joint disorder which features inflammation of one or more joints.

Compound pharmaceutical composition using glucosamine and sodium chondroitin sulfate as main medicaments

The invention discloses a compound pharmaceutical composition using glucosamine and sodium chondroitin sulfate as main medicaments, and relates to a compound pharmaceutical composition. The compound pharmaceutical composition solves the problems the conventional medicament for treating arthritis has poor treatment effect and large side effect. The compound pharmaceutical composition comprises the glucosamine, the sodium chondroitin sulfate and accessories, wherein the mass ratio of the glucosamine to the sodium chondroitin sulfate is (4-6): 4, the mass ratio of the glucosamine to the accessories is (140-160): 77, and the glucosamine is glucosamine sulfate or glucosamine hydrochloride. The glucosamine and the sodium chondroitin sulfate are synergistic for treating arthropathy, so that inflammation can be effectively resisted, repair of articular cartilages can be accelerated, synthesis of cartilage matrix is promoted, and degradation and destroy of the cartilages are reduced. The composition is applied to the field of arthritis treatment.
Owner:HEILONGJIANG DILONG PHARM CO LTD

Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging, disorders of aging, cancer, as growth factors, and as an alternative to stem cell therapy

InactiveUS20100135980A1Nervous disorderPeptide/protein ingredientsSkeletal disorderArthritis
A method for the treatment and prophylaxis of diseases or conditions associated with aging which includes oxidative stress and cancer. Such diseases or conditions are associated with a decrease or increase presence of one or a combination of one or more Carbonic Anhydrase isozymes I TO VII in the tissue of a subject. These diseases include but are not limited to chronic neurodegenerative diseases such as Alzheimer's disease, parkinson's disease, multiple sclerosis, autism, lou gehrig's disease, huntington's disease, immune disorders which includes systemic lupus erythematosus, diabetes mellitus; musculo-skeletal disorders which includes osteoporosis,arthritis, osteomalacia. Cancer which includes the breast, lung, colon, prostate gland, ovary, esophagus, liver, rectum. The method comprises administering to the patient a pharmaceutically effective non toxic amount of one or a combination of one or more compounds that increases or decreases the level of one or more Cell Specific Carbonic Anhydrase Enzymes whose levels have been increased or decreased in the tissue of the subject. Such compound maybe the Cell Specific Carbonic Anhydrase Enzymes I to VII. A compound that when absorbed reacts or dissociates to form cell specific carbonic enzymes or one or more compounds that when administered promotes the increase or decrease level of one or more cell specific Carbonic anhydrase I,II,III,IV,V,VI,VII. As growth factors of stem cells as an alternative to stem cell therapy. These methods includes the administering of one or a combination of one or more of these compounds over an extended period of time ranging from 6 months until the patient dies.
Owner:RODRIGUEZ VICTORIO C

Plaster for treating bone injuries and preparation method thereof

InactiveCN104288532ADefinite curative effectQuick resultsHeavy metal active ingredientsAnthropod material medical ingredientsSide effectCervical spondylosis
The invention belongs to the field of traditional Chinese medicine production and in particular relates to a plaster for treating bone injuries and a preparation method thereof. The plaster is prepared from the following raw materials in parts by weight: traditional Chinese medicine coarse materials, traditional Chinese medicine fine materials, vegetable oil and yellow lead. The plaster has the advantages that the used traditional Chinese medicines meet the specifications of the China Pharmacopeia and are safe and reliable; by using the medicines together, the plaster has the functions of promoting blood circulation to remove blood stasis, relieving swelling and pain, relaxing tendons and regulating qi, dispelling cold and wind and promoting reunion of fractured tendons and bones and has the characteristics of definite curative effects, quickness in effect taking, high cure rate, no side effects, and the like when being used for treating bone injuries; the main points of application of the plaster are as follows: first, the plaster is used for various organic lesions of bones and joints, such as various arthritis, scapulohumeral periarthritis, cervical spondylosis, hyperostosis, bone spurs, and the like; second, the plaster is used for various traumatic lesions of skins, skeletons and tendons and vessels, such as various traumatic injuries, fractures, spasms of tendons and vessels, and the like; and third, the plaster is used for muscle strain lesions of various parts, such as back pains, neck and shoulder (muscle) pains, and the like.
Owner:王展
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products